As p21 overexpression in B6/lpr-p21tg T cells limited autoimmune symptoms and lymphadenopathy in B6/lpr mice, we tested its potential to inhibit the severe, death-inducing autoimmunity in MRL/lpr mice. The gene discussed is CDKN1A; the disease is Lymphadenopathy.